Einfluss verschiedener medikamentöser Interventionen auf den perioperativen Verlauf von ACTH, Cortisol und immunreaktiven β-Endorphin sowie die postoperative Infektionsrate bei alkoholkranken PatientenKatrin Hegenscheid Veröffentlichungen4178910617#4831112613#44413622#168142152.1162.2634#3723173.1183.2193.33.4203.4.13.4.1.13.4.1.23.4.2213.4.2.13.4.2.23.4.3223.4.3.13.4.3.23.4.3.33.4.3.4233.4.4243.53.5.1253.5.1.13.5.1.2263.5.1.33.5.1.4273.5.1.5283.5.23.5.2.129598#5723.5.2.23.6304314.1324.24.2.133617#7604.2.2344.2.335617#75936617#7614.3374.3.1384.3.24.439457#3934.5404.6415425.15.1.14344455.1.24647485.1.34950449#256515.252535.35455421#351455#34556564#35557585.4595.5605.5.15.5.2615.5.35.5.3.1625.5.3.2635.5.3.35.5.4645.5.4.15.5.4.2655.66666768 Literaturverzeichnis69707172737475767778798081 Abkürzungsverzeichnis82 Lebenslauf83 Danksagung8485 Erklärung an Eides Statt86deInhaltsverzeichnisHilfe Literaturverzeichnis 1 Adinoff,B.; Martin,P.R.; Bone,G.H.; Eckardt,M.J.; Roehrich,L.; George,D.T.; Moss,H.B.; Eskay,R.; Linnoila,M.; Gold,P.W.: Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch.Gen.Psychiatry. 1990, 47-4, S.325-330, PM:2157379. 2 Adinoff,B.; Risher-Flowers,D.; De Jong,J.; Ravitz,B.; Bone,G.H.; Nutt,D.J.; Roehrich,L.; Martin,P.R.; Linnoila,M.: Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men. Am.J.Psychiatry. 1991, 148-8, S.1023-1025, PM:1853950. 3 Adinoff,B.; Ruether,K.; Krebaum,S.; Iranmanesh,A.; Williams,M.J.: Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol Clin.Exp.Res.. 2003, 27-9, S.1420-1427, PM:14506402. 4 Aguirre,J.C.; del Arbol,J.L.; Raya,J.; Ruiz-Requena,M.E.; Rico,Irles J.: Plasma beta-endorphin levels in chronic alcoholics. Alcohol. 1990, 7-5, S.409-412, PM:2222843. 5 Aguirre,J.C.; del Arbol,J.L.; Rico,J.; Raya,J.; Miranda,M.T.: Classification of alcoholics on the basis of plasma beta-endorphin concentration. Alcohol. 1995, 12-6, S.531-534, PM:8590614. 6 Allemann,P.I.: Markers for excessive alcohol use (screening). Ther.Umsch.. 2000, 57-4, S.185-190, PM:10804874. 7 American Psychiatric Association: Diagnostic and statistical manual of mental disorders (4th edition) (DSM-IV). American Psychiatric Association, Committee on Nomenclature and Statistics. 1994, S.195-196, 8 Aubrun,F.; Bunge,D.; Langeron,O.; Saillant,G.; Coriat,P.; Riou,B.: Postoperative morphine consumption in the elderly patient. Anesthesiology. 2003, 99-1, S.160-165, PM:12826856. 9 Bacarese-Hamilton,T.; Cattini,R.; Shandley,C.; Howard,C.; Palmer,R.; McFarthing,K.: A fully automated enzyme immunoassay for the measurement of cortisol in biological fluids. Eur.J.Clin.Chem.Clin.Biochem.. 1992, 30-9, S.531-535, PM:1457615. 10 Bertagna,X.: Proopiomelanocortin-derived peptides. Endocrinol.Metab Clin.North Am.. 1994, 23-3, S.467-485, PM:7805649. 11 Blot,W.J.; McLaughlin,J.K.; Winn,D.M.; Austin,D.F.; Greenberg,R.S.; Preston-Martin,S.; Bernstein,L.; Schoenberg,J.B.; Stemhagen,A.: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res.. 1988, 48-11, S.3282-3287, PM:3365707. 12 Blum,K.; Trachtenberg,M.C.: Alcoholism: scientific basis of a neuropsychogenetic disease. Int.J.Addict.. 1988, 23-8, S.781-796, PM:2906332. 1 3 Bone,R.C.; Balk,R.A.; Cerra,F.B.; Dellinger,R.P.; Fein,A.M.; Knaus,W.A.; Schein,R.M.; Sibbald,W.J.: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992, 101-6, S.1644-1655, PM:1303622. 14 Bornstein,S.R.; Chrousos,G.P.: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J.Clin.Endocrinol.Metab. 1999, 84-5, S.1729-1736, PM:10323408. 15 Bornstein,S.R.; Rutkowski,H.: The adrenal hormone metabolism in the immune/inflammatory reaction. Endocr.Res.. 2002, 28-4, S.719-728, PM:12530688. 16 Buckingham,J.C.: Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology. 1982, 35-2, S.111-116, PM:6290921. 17 Buckingham,J.C.; Cooper,T.A.: Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology. 1984, 38-5, S.411-417, PM:6328347. 18 Cahill,C.A.; Matthews,J.D.; Akil,H.: Human plasma beta-endorphin-like peptides: a rapid, high recovery extraction technique and validation of radioimmunoassay. J.Clin.Endocrinol.Metab. 1983, 56-5, S.992-997, PM:6300182. 19 Celis,R.; Torres,A.; Gatell,J.M.; Almela,M.; Rodriguez-Roisin,R.; Agusti-Vidal,A.: Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest. 1988, 93-2, S.318-324, PM:3338299. 20 Ceriati,F.; Tebala,G.D.; De Cosmo,G.; Saraceni,C.; Coco,C.; Bosco,F.; Mariani,L.; Ceriati,E.; Zumbo,A.: A prospective randomized clinical trial on pain control after major abdominal surgery. Chir Ital.. 2003, 55-4, S.481-489, PM:12938592. 21 Cook,R.T.: Alcohol abuse, alcoholism, and damage to the immune system-a review. Alcohol Clin.Exp.Res.. 1998, 22-9, S.1927-1942, PM:9884135. 22 Costa,A.; Bono,G.; Martignoni,E.; Merlo,P.; Sances,G.; Nappi,G.: An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. Psychoneuroendocrinology. 1996, 21-3, S.263-275, PM:8817725. 23 Craven,D.E.; Kunches,L.M.; Kilinsky,V.; Lichtenberg,D.A.; Make,B.J.; McCabe,W.R.: Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am.Rev.Respir.Dis.. 1986, 133-5, S.792-796, PM:3706887. 24 Craven,D.E.; Kunches,L.M.; Lichtenberg,D.A.; Kollisch,N.R.; Barry,M.A.; Heeren,T.C.; McCabe,W.R.: Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch.Intern.Med.. 1988, 148-5, S.1161-1168, PM:3365084. 25 Dave,J.R.; Eiden,L.E.; Karanian,J.W.; Eskay,R.L.: Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma beta-endorphin levels in the rat. Endocrinology. 1986, 118-1, S.280-286, PM:2934242. 26 del Arbol,J.L.; Aguirre,J.C.; Raya,J.; Rico,J.; Ruiz-Requena,M.E.; Miranda,M.T.: Plasma concentrations of beta-endorphin, adrenocorticotropic hormone, and cortisol in drinking and abstinent chronic alcoholics. Alcohol. 1995, 12-6, S.525-529, PM:8590613. 27 Delitala,G.; Trainer,P.J.; Oliva,O.; Fanciulli,G.; Grossman,A.B.: Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man. J.Endocrinol.. 1994, 141-1, S.163-168, PM:8031419. 28 Eggers,V.; Tio,J.; Neumann,T.; Pragst,F.; Muller,C.; Schmidt,L.G.; Kox,W.J.; Spies,C.D.: Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit. Intensive Care Med.. 2002, 28-10, S.1475-1482, PM:12373474. 29 Ehrenreich,H.; Kolmar,C.; Muller,O.A.; Goebel,F.D.: Potentiation of the hCRF-induced release of ACTH in man by an opioid antagonist. Klin.Wochenschr.. 1987, 65-10, S.453-457, PM:3037181. 30 Ehrenreich,H.; Schuck,J.; Stender,N.; Pilz,J.; Gefeller,O.; Schilling,L.; Poser,W.; Kaw,S.: Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin.Exp.Res.. 1997, 21-7, S.1285-1293, PM:9347091. 31 Engelhardt,D.: Steroid biosynthesis inhibitors in Cushing's syndrome. Clin.Investig.. 1994, 72-7, S.481-488, PM:7981573. 32 Engelhardt,D.; Weber,M.M.: Therapy of Cushing's syndrome with steroid biosynthesis inhibitors. J.Steroid Biochem.Mol.Biol.. 1994, 49-4-6, S.261-267, PM:8043488. 33 Esel,E.; Sofuoglu,S.; Aslan,S.S.; Kula,M.; Yabanoglu,I.; Turan,M.T.: Plasma levels of beta-endorphin, adrenocorticotropic hormone and cortisol during early and late alcohol withdrawal. Alcohol Alcohol. 2001, 36-6, S.572-576, PM:11704624. 34 Ewing,J.A.: Detecting alcoholism. The CAGE questionnaire. JAMA. 1984, 252-14, S.1905-1907, PM:6471323. 35 Fassbender,K.; Pargger,H.; Muller,W.; Zimmerli,W.: Interleukin-6 and acute-phase protein concentrations in surgical intensive care unit patients: diagnostic signs in nosocomial infection. Crit Care Med.. 1993, 21-8, S.1175-1180, PM:8339583. 36 Garner,J.S.; Jarvis,W.R.; Emori,T.G.; Horan,T.C.; Hughes,J.M.: CDC definitions for nosocomial infections 1988. Z.Arztl.Fortbild.(Jena). 1991, 85-17, S.818-827, PM:1659046. 37Gianoulakis,C.: The effect of ethanol on the biosynthesis and regulation of opioid peptides. Experientia. 1989, 45-5, S.428-435, PM:2656284. 38 Gianoulakis,C.; Beliveau,D.; Angelogianni,P.; Meaney,M.; Thavundayil,J.; Tawar,V.; Dumas,M.: Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci.. 1989, 45-12, S.1097-1109, PM:2529410. 39Gianoulakis,C.; Krishnan,B.; Thavundayil,J.: Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Arch.Gen.Psychiatry. 1996, 53-3, S.250-257, PM:8611062. 40 Gianoulakis,C.; de Waele,J.P.; Thavundayil,J.: Implication of the endogenous opioid system in excessive ethanol consumption. Alcohol. 1996, 13-1, S.19-23, PM:8837929. 41 Gomez-Flores,R.; Weber,R.J.: Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology. 2000, 48-2, S.145-156, PM:10936512. 42 Gronbaek,M.; Becker,U.; Johansen,D.; Tonnesen,H.; Jensen,G.; Sorensen,T.I.: Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract. BMJ. 1998, 317-7162, S.844-847, PM:9748175. 43 Groote,Veldman R.; Meinders,A.E.: On the mechanism of alcohol-induced pseudo-Cushing's syndrome. Endocr.Rev.. 1996, 17-3, S.262-268, PM:8771359. 44 Grossman,A.: Brain opiates and neuroendocrine function. Clin.Endocrinol.Metab. 1983, 12-3, S.725-746, PM:6323067. 45 Hansbrough,J.F.; Zapata-Sirvent,R.L.; Carroll,W.J.; Johnson,R.; Saunders,C.E.; Barton,C.A.: Administration of intravenous alcohol for prevention of withdrawal in alcoholic burn patients. Am.J.Surg.. 1984, 148-2, S.266-269, PM:6465435. 46 Hasselbalch,H.; Selmer,J.; Sestoft,L.; Kehlet,H.: Hypothalamic-pituitary-adrenocortical function in chronic alcoholism. Clin.Endocrinol.(Oxf). 1982, 16-1, S.73-76, PM:7074973. 47 Heil,T.; Spies,C.; Bullmann,C.; Neumann,T.; Eyrich,K.; Muller,C.; Rommelspacher,H.: The relevance of CDT (carbohydrate-deficient transferrin). Preoperative diagnosis of chronic alcohol abuse in intensive care patients following elective tumor resection. Anaesthesist. 1994, 43-7, S.447-453, PM:8092454. 48 Heil,T.; Spies,C.D.; Hannemann,L.; Reinhart,K.; Eyrich,K.: Pharmakologische Ansätze zur Prophylaxe und Therapie des postoperativen Alkoholentzugssyndroms. Anesth.Intensivmed.. 1992, 33, S.33-37, 49 Helander,A.; Husa,A.; Jeppsson,J.O.: Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin.Chem.. 2003, 49-11, S.1881-1890, PM:14578320. 50 Heuser,I.; von Bardeleben,U.; Boll,E.; Holsboer,F.: Response of ACTH and cortisol to human corticotropin-releasing hormone after short-term abstention from alcohol abuse. Biol.Psychiatry. 1988, 24-3, S.316-321, PM:2840977. 51 Holsboer,F.; Spengler,D.; Heuser,I.: The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog.Brain Res.. 1992, 93, S.385-417, PM:1336204. 52 Homann,N.: Alcohol and cancer. Ther.Umsch.. 2000, 57-4, S.236-240, PM:10804883. 53 Houghtling,R.A.; Mellon,R.D.; Tan,R.J.; Bayer,B.M.: Acute effects of morphine on blood lymphocyte proliferation and plasma IL-6 levels. Ann.N.Y.Acad.Sci.. 2000, 917, S.771-777, PM:11268406. 5 4 Hundt,W.; Zimmermann,U.; Pottig,M.; Spring,K.; Holsboer,F.: The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Alcohol Clin.Exp.Res.. 2001, 25-5, S.687-691, PM:11371718. 55 Inder,W.J.; Joyce,P.R.; Ellis,M.J.; Evans,M.J.; Livesey,J.H.; Donald,R.A.: The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides. Clin.Endocrinol.(Oxf). 1995, 43-3, S.283-290, PM:7586596. 5 6 Iranmanesh,A.; Lizarralde,G.; Johnson,M.L.; Veldhuis,J.D.: Circadian, ultradian, and episodic release of beta-endorphin in men, and its temporal coupling with cortisol. J.Clin.Endocrinol.Metab. 1989, 68-6, S.1019-1026, PM:2524500. 57 Iranmanesh,A.; Veldhuis,J.D.; Johnson,M.L.; Lizarralde,G.: 24-hour pulsatile and circadian patterns of cortisol secretion in alcoholic men. J.Androl. 1989, 10-1, S.54-63, PM:2708124. 5 8 Jeffcoate,W.: Alcohol-induced pseudo-Cushing's syndrome. Lancet. 1993, 341-8846, S.676-677, PM:8095582. 59 Jensen,N.H.; Dragsted,L.; Christensen,J.K.; Jorgensen,J.C.; Qvist,J.: Severity of illness and outcome of treatment in alcoholic patients in the intensive care unit. Intensive Care Med.. 1988, 15-1, S.19-22, PM:3230195. 60 Jessop,D.S.: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. J.Endocrinol.. 1999, 160-2, S.169-180, PM:9924185. 61 Jessop,D.S.: Stimulatory and inhibitory regulators of the hypothalamo-pituitary-adrenocortical axis. Baillieres Best.Pract.Res.Clin.Endocrinol.Metab. 1999, 13-4, S.491-501, PM:10903810. 62 Kiefer,F.; Horntrich,M.; Jahn,H.; Wiedemann,K.: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?. Psychopharmacology (Berl) . 2002, 162-4, S.433-437, PM:12172698. 63 Kikuchi,K.; Tanaka,M.; Abe,K.; Yamaguchi,K.; Kimura,S.; Adachi,I.: Rapid and specific radioimmunoassays for beta-endorphin and beta-lipotropin in affinity-purified human plasma. J.Clin.Endocrinol.Metab. 1984, 59-2, S.287-292, PM:6330153. 64 Kirkman,S.; Nelson,D.H.: Alcohol-induced pseudo-Cushing's disease: a study of prevalence with review of the literature. Metabolism. 1988, 37-4, S.390-394, PM:2833680. 65 Knaus,W.A.; Wagner,D.P.; Draper,E.A.; Zimmerman,J.E.; Bergner,M.; Bastos,P.G.; Sirio,C.A.; Murphy,D.J.; Lotring,T.; Damiano,A.; .: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991, 100-6, S.1619-1636, PM:1959406. 66 Kobayashi,Y.; Tsubota,N.; Miyai,K.; Watanabe,F.: Fluorescence quenching immunoassay of serum cortisol. Steroids. 1980, 36-2, S.177-183, PM:7444988. 67 Lee,S.; Rivier,C.: Long-term influence of an initial exposure to alcohol on the rat hypothalamic-pituitary axis. Alcohol Clin.Exp.Res.. 2003, 27-9, S.1463-1470, PM:14506408. 68 Lieber,C.S.: Medical disorders of alcoholism. N.Engl.J.Med.. 1995, 333-16, S.1058-1065, PM:7675050. 69 Lingen,M.; Sturgis,E.M.; Kies,M.S.: Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr.Opin.Oncol.. 2001, 13-3, S.176-182, PM:11307061. 70 MacGregor,R.R.; Louria,D.B.: Alcohol and infection. Curr.Clin.Top.Infect.Dis.. 1997, 17, S.291-315, PM:9189671. 71 Malangoni,M.A.; Crafton,R.; Mocek,F.C.: Pneumonia in the surgical intensive care unit: factors determining successful outcome. Am.J.Surg.. 1994, 167-2, S.250-255, PM:8135314. 72 Marchesi,C.; Chiodera,P.; Ampollini,P.; Volpi,R.; Coiro,V.: Beta-endorphin, adrenocorticotropic hormone and cortisol secretion in abstinent alcoholics. Psychiatry Res.. 1997, 72-3, S.187-194, PM:9406908. 73 Marx,C.; Ehrhart-Bornstein,M.; Scherbaum,W.A.; Bornstein,S.R.: Regulation of adrenocortical function by cytokines--relevance for immune-endocrine interaction. Horm.Metab Res.. 1998, 30-6-7, S.416-420, PM:9694572. 74 McDonald,R.K.; Evans,F.T.; Weise,V.K.; Patrick,R.W.: Effect of morphine and nalorphine on plasma hydrocortisone levels in man. J.Pharmacol.Exp.Ther.. 1959, 125-3, S.241-247, PM:13642265. 75 Mendenhall,C.L.; Theus,S.A.; Roselle,G.A.; Grossman,C.J.; Rouster,S.D.: Biphasic in vivo immune function after low- versus high-dose alcohol consumption. Alcohol. 1997, 14-3, S.255-260, PM:9160803. 76 Merry,J.; Marks,V.: The effects of alcohol, barbiturate, and diazepam on hypothalamic-pituitary-adrenal function in chronic alcoholics. Lancet. 1972, 2-7785, S.990-991, PM:4116981. 77 Miller,J.W.; Crapo,L.: The medical treatment of Cushing's syndrome. Endocr.Rev.. 1993, 14-4, S.443-458, PM:7693447. 78 Moore,R.D.; Bone,L.R.; Geller,G.; Mamon,J.A.; Stokes,E.J.; Levine,D.M.: Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA. 1989, 261-3, S.403-407, PM:2909780. 79 Morgan,M.Y.: Alcohol and the endocrine system. Br.Med.Bull.. 1982, 38-1, S.35-42, PM:7046871. 80 Morita,M.; Saeki,H.; Mori,M.; Kuwano,H.; Sugimachi,K.: Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery . 2002, 131-1 Suppl, S.S1-S6, PM:11821780. 81 Mortimer,R.H.; Cannell,G.R.; Thew,C.M.; Galligan,J.P.: Ketoconazole and plasma and urine steroid levels in Cushing's disease. Clin.Exp.Pharmacol.Physiol. 1991, 18-8, S.563-569, PM:1655322. 82 Mulla,A.; Buckingham,J.C.: Regulation of the hypothalamo-pituitary-adrenal axis by cytokines. Baillieres Best.Pract.Res.Clin.Endocrinol.Metab. 1999, 13-4, S.503-521, PM:10903811. 83 Munson,P.L.: Effects of morphine and related drugs on the corticotrophin (ACTH)-stress reaction. Prog.Brain Res.. 1973, 39, S.361-372, PM:4363913. 84 Myers,R.D.; Melchior,C.L.: Alcohol drinking: abnormal intake caused by tetrahydropapaveroline in brain. Science. 1977, 196-4289, S.554-556, PM:557839. 85 Myers,R.D.; Critcher,E.C.: Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV. Pharmacol.Biochem.Behav.. 1982, 16-5, S.827-836, PM:6283568. 86 Napolitano,L.M.; Koruda,M.J.; Zimmerman,K.; McCowan,K.; Chang,J.; Meyer,A.A.: Chronic ethanol intake and burn injury: evidence for synergistic alteration in gut and immune integrity. J.Trauma. 1995, 38-2, S.198-207, PM:7869435. 87 Neumann,T.; Spies,C.D.: Use of biomarkers for alcohol use disorders in clinical practice. Addiction. 2003, 98, S.S2, 88 Nieman,L.K.: Medical therapy of Cushing's disease. Pituitary.. 2002, 5-2, S.77-82, PM:12675504. 89 Pilz,G.; Werdan,K.: Scores for multiple organ dysfunction and multiple organ failure. Internist (Berl). 1998, 39-5, S.502-508, PM:9647985. 90 Raff,H.; Shaker,J.L.; Nelson,D.K.; Findling,J.W.: Rapid measurement of corticotropin (ACTH) with a modified immunochemiluminescent assay. Clin.Chem.. 1994, 40-7, S.1344, PM:8013111. 91 Rantala,A.; Lehtonen,O.P.; Niinikoski,J.: Alcohol abuse: a risk factor for surgical wound infections?. Am.J.Infect.Control. 1997, 25-5, S.381-386, PM:9343620. 92 Rasmussen,D.D.; Boldt,B.M.; Bryant,C.A.; Mitton,D.R.; Larsen,S.A.; Wilkinson,C.W.: Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin.Exp.Res.. 2000, 24-12, S.1836-1849, PM:11141043. 93 Rees,L.H.; Besser,G.M.; Jeffcoate,W.J.; Goldie,D.J.; Marks,V.: Alcohol-induced pseudo-Cushing's syndrome. Lancet. 1977, 1-8014, S.726-728, PM:66521. 94 Ringborg,U.: Alcohol and risk of cancer. Alcohol Clin.Exp.Res.. 1998, 22-7 Suppl, S.323S-328S, PM:9799956. 95 Rittmaster,R.S.; Cutler,G.B.,Jr.; Sobel,D.O.; Goldstein,D.S.; Koppelman,M.C.; Loriaux,D.L.; Chrousos,G.P.: Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J.Clin.Endocrinol.Metab. 1985, 60-5, S.891-895, PM:2984235. 96 Rivier,C.; Bruhn,T.; Vale,W.: Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J.Pharmacol.Exp.Ther.. 1984, 229-1, S.127-131, PM:6323684. 97 Rivier,C.; Vale,W.: Interaction between ethanol and stress on ACTH and beta-endorphin secretion. Alcohol Clin.Exp.Res.. 1988, 12-2, S.206-210, PM:2837103. 98 Rivier,C.: Alcohol stimulates ACTH secretion in the rat: mechanisms of action and interactions with other stimuli. Alcohol Clin.Exp.Res.. 1996, 20-2, S.240-254, PM:8730214. 99 Rivier,C.L.; Grigoriadis,D.E.; Rivier,J.E.: Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology. 2003, 144-6, S.2396-2403, PM:12746300. 100 Rodriguez,J.L.; Gibbons,K.J.; Bitzer,L.G.; Dechert,R.E.; Steinberg,S.M.; Flint,L.M.: Pneumonia: incidence, risk factors, and outcome in injured patients. J.Trauma. 1991, 31-7, S.907-912, PM:2072428. 10 1 Rosenberger,P.; Muhlbauer,E.; Weissmuller,T.; Rommelspacher,H.; Sinha,P.; Wernecke,K.D.; Finckh,U.; Rettig,J.; Kox,W.J.; Spies,C.D.: Decreased proopiomelanocortin mRNA in lymphocytes of chronic alcoholics after intravenous human corticotropin releasing factor injection. Alcohol Clin.Exp.Res.. 2003, 27-11, S.1693-1700, PM:14634483. 102 Roth-Isigkeit,A.; Dibbelt,L.; Schmucker,P.; Seyfarth,M.: The immune-endocrine interaction varies with the duration of the inflammatory process in cardiac surgery patients. J.Neuroendocrinol.. 2000, 12-6, S.546-552, PM:10844583. 103 Roth-Isigkeit,A.K.; Schmucker,P.: Postoperative dissociation of blood levels of cortisol and adrenocorticotropin after coronary artery bypass grafting surgery. Steroids. 1997, 62-11, S.695-699, PM:9366007. 104 Roth-Isigkeit,A.K.; Dibbelt,L.; Schmucker,P.: Blood levels of corticosteroid-binding globulin, total cortisol and unbound cortisol in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass. Steroids. 2000, 65-9, S.513-520, PM:10978730. 105 Ruckert,R.I.; Hoffmann,Y.; Rohde,W.: Some methodic aspects in optimizing the radioimmunoassay of beta-endorphin. Exp.Clin.Endocrinol.. 1986, 87-3, S.277-287, PM:2946595. 106 Saitz,R.; Ghali,W.A.; Moskowitz,M.A.: The impact of alcohol-related diagnoses on pneumonia outcomes. Arch.Intern.Med.. 1997, 157-13, S.1446-1452, PM:9224223. 107 Sander,M.; Irwin,M.; Sinha,P.; Naumann,E.; Kox,W.J.; Spies,C.D.: Suppression of interleukin-6 to interleukin-10 ratio in chronic alcoholics: association with postoperative infections. Intensive Care Med.. 2002, 28-3, S.285-292, PM:11904657. 108 Schafer,M.; Mousa,S.A.; Stein,C.: Corticotropin-releasing factor in antinociception and inflammation. Eur.J.Pharmacol.. 1997, 323-1, S.1-10, PM:9105870. 109 Schein,R.M.; Sprung,C.L.; Marcial,E.; Napolitano,L.; Chernow,B.: Plasma cortisol levels in patients with septic shock. Crit Care Med.. 1990, 18-3, S.259-263, PM:2302948. 110 Schroeder,S.; Wichers,M.; Klingmuller,D.; Hofer,M.; Lehmann,L.E.; von Spiegel,T.; Hering,R.; Putensen,C.; Hoeft,A.; Stuber,F.: The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med.. 2001, 29-2, S.310-316, PM:11246311. 111 Seitz,H.K.; Simanowski,U.A.: Ethanol and carcinogenesis of the alimentary tract. Alcohol Clin.Exp.Res.. 1986, 10-6 Suppl, S.33S-40S, PM:3544928. 11 2 Seitz,H.K.; Poschl,G.; Simanowski,U.A.: Alcohol and cancer. Recent Dev.Alcohol. 1998, 14, S.67-95, PM:9751943. 113 Sonino,N.; Boscaro,M.; Paoletta,A.; Mantero,F.; Ziliotto,D.: Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin.Endocrinol.(Oxf). 1991, 35-4, S.347-352, PM:1752063. 114 Spencer,R.L.; McEwen,B.S.: Adaptation of the hypothalamic-pituitary-adrenal axis to chronic ethanol stress. Neuroendocrinology. 1990, 52-5, S.481-489, PM:2126355. 115 Spies,C.: Anesthesiologic aspects of chronic alcohol abuse. Ther.Umsch.. 2000, 57-4, S.261-63, PM:10804888. 116 Spies,C.; Tonnesen,H.; Andreasson,S.; Helander,A.; Conigrave,K.: Perioperative morbidity and mortality in chronic alcoholic patients. Alcohol Clin.Exp.Res.. 2001, 25-5 Suppl, S.164S-170S, PM:11391067. 117 Spies,C.D.; Rommelspacher,H.; Schnapper,C.; Muller,C.; Marks,C.; Berger,G.; Conrad,C.; Blum,S.; Specht,M.; Hannemann,L.; .: Beta-carbolines in chronic alcoholics undergoing elective tumor resection. Alcohol Clin.Exp.Res.. 1995, 19-4, S.969-976, PM:7485848. 118 Spies,C.D.; Dubisz,N.; Funk,W.; Blum,S.; Muller,C.; Rommelspacher,H.; Brummer,G.; Specht,M.; Hannemann,L.; Striebel,H.W.; .: Prophylaxis of alcohol withdrawal syndrome in alcohol-dependent patients admitted to the intensive care unit after tumour resection. Br.J.Anaesth.. 1995, 75-6, S.734-739, PM:8672322. 119 Spies,C.D.; Nordmann,A.; Brummer,G.; Marks,C.; Conrad,C.; Berger,G.; Runkel,N.; Neumann,T.; Muller,C.; Rommelspacher,H.; Specht,M.; Hannemann,L.; Striebel,H.W.; Schaffartzik,W.: Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract. Acta Anaesthesiol.Scand.. 1996, 40-6, S.649-656, PM:8836256. 120 Spies,C.D.; Neuner,B.; Neumann,T.; Blum,S.; Muller,C.; Rommelspacher,H.; Rieger,A.; Sanft,C.; Specht,M.; Hannemann,L.; Striebel,H.W.; Schaffartzik,W.: Intercurrent complications in chronic alcoholic men admitted to the intensive care unit following trauma. Intensive Care Med.. 1996, 22-4, S.286-293, PM:8708164. 121 Spies,C.D.; Dubisz,N.; Neumann,T.; Blum,S.; Muller,C.; Rommelspacher,H.; Brummer,G.; Specht,M.; Sanft,C.; Hannemann,L.; Striebel,H.W.; Schaffartzik,W.: Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Crit Care Med.. 1996, 24-3, S.414-422, PM:8625628. 122 Spies,C.D.; Rommelspacher,H.: Alcohol withdrawal in the surgical patient: prevention and treatment. Anesth.Analg.. 1999, 88-4, S.946-954, PM:10195555. 123 Spies,CD; von Dossw,V.; Eggers,V.; Jetschmann,G.; El-Hilali,R.; Egert,J.; Fischer,M.; Schröder,T.; Höflich,C.; Sinha,P.; Paschen,C.; Mirsalim,P.; Brunsch,R.; Hopf,J.; Marks,C.; Wernecke,KD.; Pragst,F.; Ehrenreich,H.; Müller,C.; Tonnesen,H.; Oelkers,W.; Rohde,W.; Stein,C.; Kox,WJ.: Altered cell-mediated immunity and increased postoperative infection rate in chronic alcoholic patients. Anesthesiology. 2004, 124 Suemaru,S.; Hashimoto,K.; Ota,Z.: Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats. Acta Med.Okayama. 1985, 39-6, S.463-470, PM:3004111. 125 Suemaru,S.; Hashimoto,K.; Ota,Z.: Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity. Endocrinol.Jpn.. 1986, 33-4, S.441-448, PM:3024953. 126 Suemaru,S.; Dallman,M.F.; Darlington,D.N.; Cascio,C.S.; Shinsako,J.: Role of alpha- adrenergic mechanism in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat. Neuroendocrinology. 1989, 49-2, S.181-190, PM:2542829. 127 Sullivan,J.T.; Sykora,K.; Schneiderman,J.; Naranjo,C.A.; Sellers,E.M.: Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br.J.Addict.. 1989, 84-11, S.1353-1357, PM:2597811. 128 Szabo,G.: Consequences of alcohol consumption on host defence. Alcohol Alcohol. 1999, 34-6, S.830-841, PM:10659718. 129 Szabo,J.; Bruckner,G.; Medveczky,I.; Kosa,E.; Balogh,A.: Ethanol's effect on rat pituitary adrenal axis is prevented by purine metabolic pathway inhibitors. Proc.Soc.Exp.Biol.Med.. 1999, 220-2, S.112-118, PM:9933506. 130 Talbot,J.A.; Kane,J.W.; White,A.: Analytical and clinical aspects of adrenocorticotrophin determination. Ann.Clin.Biochem.. 2003, 40-5, S.453-471, PM:14503983. 131 Terzolo,M.; Panarelli,M.; Piovesan,A.; Torta,M.; Paccotti,P.; Angeli,A.: Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol. J.Endocrinol.Invest. 1988, 11-10, S.717-721, PM:2852693. 13 2 Tonnesen,H.; Petersen,K.R.; Hojgaard,L.; Stokholm,K.H.; Nielsen,H.J.; Knigge,U.; Kehlet,H.: Postoperative morbidity among symptom-free alcohol misusers. Lancet. 1992, 340-8815, S.334-337, PM:1353805. 133 Tonnesen,H.; Kaiser,A.H.; Nielsen,B.B.; Pedersen,A.E.: Reversibility of alcohol-induced immune depression. Br.J.Addict.. 1992, 87-7, S.1025-1028, PM:1643394. 134 Tonnesen,H.: Influence of alcohol on several physiological functions and its reversibility: a surgical view. Acta Psychiatr.Scand.Suppl. 1992, 369, S.67-71, PM:1471555. 135 Tonnesen,H.: The alcohol patient and surgery. Alcohol Alcohol. 1999, 34-2, S.148-152, PM:10344774. 136 Tonnesen,H.; Rosenberg,J.; Nielsen,H.J.; Rasmussen,V.; Hauge,C.; Pedersen,I.K.; Kehlet,H.: Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ. 1999, 318-7194, S.1311-1316, PM:10323814. 137 Tonnesen,H.; Kehlet,H.: Preoperative alcoholism and postoperative morbidity. Br.J.Surg.. 1999, 86-7, S.869-874, PM:10417555. 138 Tsueda,K.; Loyd,G.E.; Heine,M.F.; Duque,F.; Haas,J.E.; Stocking,J.E.: Opiates in ethanol withdrawal. Anesth.Analg.. 1995, 81-4, S.874-877, PM:7574028. 139 van Nieuwenhoven,E.J.; Lefering,R.; Neugebauer,E.; Goris,R.J.: Clinical relevance of sepsis scores. Langenbecks Arch.Surg.. 1998, 383-1, S.11-14, PM:9627166. 140 von Bardeleben,U.; Heuser,I.; Holsboer,F.: Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoneuroendocrinology. 1989, 14-6, S.441-449, PM:2560222. 141 von Heymann,C.; Langenkamp,J.; Dubisz,N.; von,Dossow,V; Schaffartzik,W.; Kern,H.; Kox,W.J.; Spies,C.: Posttraumatic immune modulation in chronic alcoholics is associated with multiple organ dysfunction syndrome. J.Trauma. 2002, 52-1, S.95-103, PM:11791058. 142 Wand,G.S.; Dobs,A.S.: Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J.Clin.Endocrinol.Metab. 1991, 72-6, S.1290-1295, Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. 143 Wardlaw,S.L.; Frantz,A.G.: Measurement of beta-endorphin in human plasma. J.Clin.Endocrinol.Metab . 1979, 48-1, S.176-180, PM:84817. 144 Williams,K.L.; Ko,M.C.; Rice,K.C.; Woods,J.H.: Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Psychoneuroendocrinology. 2003, 28-4, S.513-528, PM:12689609. 145 Yamaguchi,H.; Liotta,A.S.; Krieger,D.T.: Simultaneous determination of human plasma immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin using immuno-affinity chromatography. J.Clin.Endocrinol.Metab. 1980, 51-5, S.1002-1008, PM:6252227. 146Young,D.S.: Implementation of SI units for clinical laboratory data. Style specifications and conversion tables. Ann.Intern.Med.. 1987, 106-1, S.114-129, PM:3789557. 147 Zhou,Y.; Spangler,R.; Maggos,C.E.; Wang,X.M.; Han,J.S.; Ho,A.; Kreek,M.J.: Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress. J.Endocrinol.. 1999, 163-2, S.261-267, PM:10556776. 148 Zimmermann,U.; Hundt,W.; Spring,K.; Grabner,A.; Holsboer,F.: Hypothalamic-pituitary-adrenal system adaptation to detoxification in alcohol-dependent patients is affected by family history of alcoholism. Biol.Psychiatry. 2003, 53-1, S.75-84, PM:12513947.